MedTrace Logo

The Use of Major Depression Inventory (MDI) in Measuring Preoperative Depressive Symptoms in Breast Cancer Patients

NCT01284751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2011-05-12

No results posted yet for this study

Summary

The purpose of this study is to measure depressive symptoms in breast cancer patients before surgery with Major Depression Inventory (MDI). The investigators hypothesize that this patient group will not produce scores correlating to having a mild, moderate or severe depression even though they have just recently experienced a major life crisis by receiving a malignant diagnosis.

Conditions

Interventions

OTHER

MDI - self-rating inventory

MDI with 12 questions to be completed approximately 1 week before surgery

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Melissa V Hansen, MD · Herlev Hospital

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01284751 on ClinicalTrials.gov